Key result
Periodontitis is linked to ~3-fold higher serum NT-proBNP levels versus controls.
Why the study?
Little is known about the potential role of NT-proBNP in periodontal disease despite its expression during inflammation and association with cardiovascular disease.
Are serum NT-proBNP levels elevated in patients with periodontitis compared to nonperiodontitis controls?
Case-Control (n=80)
Are serum NT-proBNP levels elevated in patients with periodontitis compared to nonperiodontitis controls?
Periodontitis is associated with elevated serum NT-proBNP levels, which correlate with the severity of periodontal inflammation, suggesting a potential link to cardiovascular disease risk.
Answers are grounded in this paper and cite their sources.
Elevated NT-proBNP in periodontitis may flag higher CVD risk; leaves open whether treatment modifies levels or events.
Background and Objective N‐terminal‐pro‐brain natriuretic peptide (NT‐proBNP) is expressed during inflammation and considered to be a biomarker of cardiovascular disease (CVD). In the last decade, evidence has suggested that periodontitis is associated with CVD. However, little is known of the potential role of this peptide in periodontal disease. The aims of this study were to examine whether the levels of NT‐proBNP in serum are increased in periodontal disease and if there is a relationship to severity of periodontitis. Material and Methods A case‐control study was carried out, in which serum samples were collected from 40 patients with periodontitis and from 40 nonperiodontitis individuals. Full periodontal examination was performed in all subjects. Demographic information, and clinical and history of certain diseases were also recorded. Determinations of serum NT‐proBNP and high‐sensitivity C‐reactive protein concentrations were carried out in an independent laboratory. Results The levels of NT‐proBNP in serum were significantly higher in patients with periodontitis compared with controls (87.9 pg/mL vs 29.9 pg/mL, P < .0001). In addition, as periodontal disease progressed, the levels of NT‐proBNP increased. Multivariable regression analysis showed that the periodontal inflamed surface area, a measure of periodontal inflammation and disease activity, was the only periodontal parameter significantly associated with elevated concentrations of NT‐proBNP in serum (R2 = .777, P < .0001). Conclusion In periodontitis, increased serum NT‐proBNP levels are observed in comparison with individuals without periodontitis. Moreover, the greater the degree of periodontal destruction, the higher the levels of NT‐proBNP in serum.
No takes yet. Share an insight, caveat, or question.
Leira et al. (2018) conducted a case-control in Periodontitis (n=80). Periodontitis vs. Nonperiodontitis individuals was evaluated on Serum NT-proBNP levels (p=<.0001). Patients with periodontitis had higher serum NT-proBNP levels compared to controls, and levels increased with greater periodontal destruction.
Synapse has enriched 10 related papers. Consider them for comparative context: